Gene Therapy Fully Reverses Friedreich’s Ataxia Changes in Mouse Model, Study Shows – Friedreich’s Ataxia News
Friedreich’s Ataxia News |
Gene Therapy Fully Reverses Friedreich’s Ataxia Changes in Mouse Model, Study Shows
Friedreich’s Ataxia News Possible therapies for FA may come from diverse approaches, including gene therapy. The authors previously showed that a gene therapy strategy using harmless viruses to deliver frataxin could prevent and reverse cardiomyopathy, or heart muscle disease, … |
Friedreich’s Ataxia News |
Gene Therapy Fully Reverses Friedreich’s Ataxia Changes in Mouse Model, Study Shows
Friedreich’s Ataxia News Possible therapies for FA may come from diverse approaches, including gene therapy. The authors previously showed that a gene therapy strategy using harmless viruses to deliver frataxin could prevent and reverse cardiomyopathy, or heart muscle disease, … |
Long Island Weekly News |
Little Stem Cell Recipient Meets His Donor At 19th Annual Party For Life
Long Island Weekly News Kids Need More, the Suffolk-based nonprofit, recently hosted its 19th Annual Party for Life in memory of Peter Careccia. Watch MyLITV’s coverage of the event that facilitated a heartwarming meeting between a bone marrow donor and recipient. SHARE. |
Schaeffers Research (blog) |
Analyst: This Gene Therapy Stock Could Soar 90%
Schaeffers Research (blog) The shares of gene therapy concern Abeona Therapeutics Inc (NASDAQ:ABEO) are set for their best day in nearly two months, up 15.5% to trade at $17.92, thanks to a bullish analyst note. Specifically, Seaport Global started coverage of ABEO stock with a … Abeona Therapeutics Opens New Manufacturing Facility in Ohio for Its Gene, Cell TherapiesSanfilippo News UPDATE: Seaport Starts Abeona Therapeutics (ABEO) at Buy, Likes the Powerful R&D PipelineStreetInsider.com Analysts at HC Wainwright Maintained their Past ‘”Buy”’ rating on Shares Abeona Therapeutics (NASDAQ:ABEO), Set a …Frisco Fastball Week Herald all 65 news articles » |
The Scientist |
New Insights to Improve CAR T Cells‘ Safety
The Scientist From the first infusion of CAR T cells in humans in 2009, scientists observed increased levels of cytokines in patients, explains Michel Sadelain, a cancer researcher at Memorial Sloan Kettering Cancer Center, a coauthor of one of the studies, and the … |
Bulletin of the Atomic Scientists |
Crispr goes global: A snapshot of rules, policies, and attitudes
Bulletin of the Atomic Scientists The gene editing technology Crispr has been in the news a great deal over the last few years. Just last week, the prestigious (and lucrative) Kavli Prize was awarded to the technology’s originators—UC Berkeley’s Jennifer Doudna, her French … |